{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:47:35Z","timestamp":1776872855093,"version":"3.51.2"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s10067-019-04528-y","type":"journal-article","created":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T11:25:16Z","timestamp":1554117916000},"page":"2069-2075","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Cardiac and cardiovascular morbidities in patients with psoriatic arthritis: a population-based case control study"],"prefix":"10.1007","volume":"38","author":[{"given":"Adi","family":"Kibari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnon D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tal","family":"Gazitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haim","family":"Bitterman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Idit","family":"Lavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilan","family":"Feldhamer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Shalom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sari","family":"Greenberg-Dotan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0523-2292","authenticated-orcid":false,"given":"Devy","family":"Zisman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,1]]},"reference":[{"key":"4528_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s11926-010-0112-3","volume":"12","author":"ME Husni","year":"2010","unstructured":"Husni ME, Mease PJ (2010) Managing comorbid disease in patients with psoriatic arthritis. Curr Rheumatol Rep 12:281\u2013287","journal-title":"Curr Rheumatol Rep"},{"key":"4528_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/jdv.12163","volume":"27","author":"C Horreau","year":"2013","unstructured":"Horreau C, Pouplard C, Brenaut E, Barnetche T, Misery L, Cribier B, Jullien D, Aractingi S, Aubin F, Joly P, le Ma\u00eetre M, Ortonne JP, Paul C, Richard MA (2013) Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol 27:12\u201329","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4528_CR3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/rheumatology\/kes242","volume":"52","author":"A Russolillo","year":"2013","unstructured":"Russolillo A, Iervolino S, Peluso R, Lupoli R, di Minno A, Pappone N, di Minno MND (2013) Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management. Rheumatol 52:62\u201367","journal-title":"Rheumatol"},{"key":"4528_CR4","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1093\/rheumatology\/ken090","volume":"47","author":"LS Tam","year":"2008","unstructured":"Tam LS, Tomlinson B, Chu TW et al (2008) Cardiovascular risk profile of patients with psoriatic arthritis compared to controls\u2014the role of inflammation. Rheumatol 47:718\u2013723","journal-title":"Rheumatol"},{"key":"4528_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/annrheumdis-2011-201194","volume":"72","author":"A Jamnitski","year":"2013","unstructured":"Jamnitski A, Symmons D, Peters MJ et al (2013) Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Ann Rheum Dis 72:211\u2013216","journal-title":"Ann Rheum Dis"},{"key":"4528_CR6","first-page":"2167","volume":"33","author":"C Han","year":"2006","unstructured":"Han C, Robinson DW, Hackett MV et al (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33:2167\u20132172","journal-title":"J Rheumatol"},{"key":"4528_CR7","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1136\/ard.2008.094839","volume":"68","author":"DD Gladman","year":"2009","unstructured":"Gladman DD, Ang M, Su L, Tom BD et al (2009) Cardiovascular morbidity in psoriatic arthritis. Ann Rheum Dis 68:1131\u20131135","journal-title":"Ann Rheum Dis"},{"key":"4528_CR8","first-page":"404","volume":"3","author":"G Rennert","year":"2001","unstructured":"Rennert G, Peterburg Y (2001) Prevalence of selected chronic diseases in Israel. Isr Med Assoc J 3:404\u2013408","journal-title":"Isr Med Assoc J"},{"key":"4528_CR9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1136\/annrheumdis-2013-205148","volume":"75","author":"D Zisman","year":"2016","unstructured":"Zisman D, Bitterman H, Shalom G, Feldhamer I, Comanesther D, Batat E, Greenberg-Dotan S, Cohen S, Cohen AD (2016) Psoriatic arthritis treatment and the risk of herpes zoster. Ann Rheum Dis 75:131\u2013135","journal-title":"Ann Rheum Dis"},{"key":"4528_CR10","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/j.1468-3083.2011.04230.x","volume":"26","author":"J Dreiher","year":"2012","unstructured":"Dreiher J, Kresch FS, Comaneshter D, Cohen AD (2012) Risk of Herpes zoster in patients with psoriasis treated with biologic drugs. J Eur Acad Dermatol Venereol 26:1127\u20131132","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4528_CR11","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000286131","volume":"220","author":"AD Cohen","year":"2010","unstructured":"Cohen AD, Weitzman D, Birkenfeld S, Dreiher J (2010) Psoriasis associated with hepatitis C but not with hepatitis B. Dermatol 220:218\u2013222","journal-title":"Dermatol"},{"key":"4528_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.semarthrit.2006.09.001","volume":"36","author":"O Kimhi","year":"2007","unstructured":"Kimhi O, Caspi D, Bornstein NM, Maharshak N, Gur A, Arbel Y, Comaneshter D, Paran D, Wigler I, Levartovsky D, Berliner S (2007) Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Semin Arthritis Rheum 36:203\u2013209","journal-title":"Semin Arthritis Rheum"},{"key":"4528_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/acr.20363","volume":"63","author":"CC Mok","year":"2011","unstructured":"Mok CC, Ko GTC, Ho LY, Yu KL, Chan PT, To CH (2011) Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis. Arthritis Care Res 63:195\u2013202","journal-title":"Arthritis Care Res"},{"key":"4528_CR14","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s10067-014-2743-7","volume":"33","author":"M Khraishi","year":"2014","unstructured":"Khraishi M, Aslanov R, Rampakakis E, Pollock C, Sampalis JS (2014) Prevalence of cardiovascular risk factors in patients with psoriatic arthritis. Clin Rheumatol 33:1495\u20131500","journal-title":"Clin Rheumatol"},{"key":"4528_CR15","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/annrheumdis-2014-206824","volume":"75","author":"AM Gulati","year":"2016","unstructured":"Gulati AM, Semb AG, Rollefstad S, Romundstad PR, Kavanaugh A, Gulati S, Haugeberg G, Hoff M (2016) On the HUNT for cardiovascular risk factors and disease in patients with psoriatic arthritis: population-based data from the Nord-Tr\u00f8ndelag Health Study. Ann Rheum Dis 75:819\u2013824","journal-title":"Ann Rheum Dis"},{"key":"4528_CR16","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/annrheumdis-2011-200567","volume":"71","author":"H Johnsson","year":"2012","unstructured":"Johnsson H, McInnes IB, Sattar N (2012) Cardiovascular and metabolic risks in psoriasis and psoriatic arthritis: pragmatic clinical management based on available evidence. Ann Rheum Dis 71:480\u2013483. \n                              https:\/\/doi.org\/10.1136\/annrheumdis-2011-200567","journal-title":"Ann Rheum Dis"},{"key":"4528_CR17","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.semarthrit.2004.07.010","volume":"34","author":"MJ Peters","year":"2004","unstructured":"Peters MJ, van der Horst-Bruinsma IE, Dijkmans BA, Nurmohamed MT (2004) Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 34:585\u2013592","journal-title":"Semin Arthritis Rheum"},{"key":"4528_CR18","unstructured":"Cognitive impairment in patients with psoriasis: a matched case-control study. Innamorati M1, Quinto RM2, Lester D3, Iani L2, Graceffa D4, Bonifati C4"},{"key":"4528_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12991-014-0038-7","volume":"13","author":"P Korkoliakou","year":"2014","unstructured":"Korkoliakou P, Christodoulou C, Kouris A et al (2014) Alexithymia, anxiety and depression in patients with psoriasis: a case\u2013control study. Ann General Psychiatry 13:1","journal-title":"Ann General Psychiatry"},{"key":"4528_CR20","doi-asserted-by":"publisher","unstructured":"Gezer O, Batmaz \u0130, Sariyildiz MA et al (2014) Sleep quality in patients with psoriatic arthritis. Int J Rheum Dis. \n                              https:\/\/doi.org\/10.1111\/1756-185X.1250","DOI":"10.1111\/1756-185X.1250"},{"key":"4528_CR21","first-page":"289","volume":"31","author":"A Reich","year":"2014","unstructured":"Reich A, Welz-Kubiak K, Rams L (2014) Apprehension of the disease by patients suffering from psoriasis. Postep Derm Alergol 31:289\u2013293","journal-title":"Postep Derm Alergol"},{"key":"4528_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jad.2010.02.112","volume":"125","author":"N Vogelzangs","year":"2010","unstructured":"Vogelzangs N, Seldenrijk A, Beekman AT et al (2010) Cardiovascular disease in persons with depressive and anxiety disorders. J Affect Disord 125:241\u2013248","journal-title":"J Affect Disord"},{"key":"4528_CR23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jaad.2010.11.046","volume":"66","author":"J Shapiro","year":"2012","unstructured":"Shapiro J, Cohen AD, Weitzman D, Tal R, David M (2012) Psoriasis and cardiovascular risk factors: a case-control study on inpatients comparing psoriasis to dermatitis. J Am Acad Dermatol 66:252\u2013258","journal-title":"J Am Acad Dermatol"},{"key":"4528_CR24","doi-asserted-by":"publisher","first-page":"506","DOI":"10.2340\/00015555-0297","volume":"87","author":"AD Cohen","year":"2007","unstructured":"Cohen AD, Gilutz H, Henkin Y, Zahger D, Shapiro J, Bonneh DY, Vardy DA (2007) Psoriasis and the metabolic syndrome. Acta Derm Venereol 87:506\u2013509","journal-title":"Acta Derm Venereol"},{"key":"4528_CR25","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jaad.2017.04.1133","volume":"77","author":"MJM Rodriguez-Z\u00fa\u00f1iga","year":"2017","unstructured":"Rodriguez-Z\u00fa\u00f1iga MJM, Garcia-Perdomo HA (2017) J Am Acad Dermatol 77:657\u2013666.e8","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"4528_CR26","first-page":"809","volume":"95","author":"A Svedbom","year":"2015","unstructured":"Svedbom A, Dal\u00e9n J, Mamolo C et al (2015) Increased cause-specific mortality in patients with mild and severe psoriasis: a population-based Swedish register. Acta Derm Venereol 95(7):809\u2013815","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"4528_CR27","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00059-005-2730-5","volume":"30","author":"B Maisch","year":"2005","unstructured":"Maisch B, Richter A, Sandm\u00f6ller A, Portig I, Pankuweit S, for the members of project 9a in the BMBF-Heart Failure Network (2005) Inflammatory dilated cardiomyopathy (DCMI). Herz. 30(6):535\u2013544","journal-title":"Herz."},{"issue":"6","key":"4528_CR28","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1177\/147323000603400608","volume":"34","author":"I Biyik","year":"2006","unstructured":"Biyik I, Narin A, Bozok MA, Ergene O (2006) Echocardiographic and clinical abnormalities in patients with psoriasis. J Int Med Res 34(6):632\u2013639","journal-title":"J Int Med Res"},{"issue":"12","key":"4528_CR29","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.autrev.2011.05.022","volume":"10","author":"R Ramonda","year":"2011","unstructured":"Ramonda R, Lo Nigro A, Modesti V, Nalotto L, Musacchio E, Iaccarino L, Punzi L, Doria A (2011) Atherosclerosis in psoriatic arthritis. Autoimmun Rev 10(12):773\u2013778","journal-title":"Autoimmun Rev"},{"key":"4528_CR30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00296-016-3487-2","volume":"37","author":"KM Yim","year":"2016","unstructured":"Yim KM, Armstrong AW (2016) Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms. Rheumatol Int 37:97\u2013105. \n                              https:\/\/doi.org\/10.1007\/s00296-016-3487-2","journal-title":"Rheumatol Int"},{"key":"4528_CR31","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11926-012-0260-8","volume":"14","author":"WH Boehncke","year":"2012","unstructured":"Boehncke WH, Boehncke S (2012) Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives. Curr Rheumatol Rep 14:343\u2013348","journal-title":"Curr Rheumatol Rep"},{"key":"4528_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4081\/reumatismo.2011.148","volume":"63","author":"F Atzeni","year":"2011","unstructured":"Atzeni F, Turiel M, Boccassini L et al (2011) Cardiovascular involvement in psoriatic arthritis. Reumatismo 63:148\u2013154","journal-title":"Reumatismo"},{"key":"4528_CR33","first-page":"877","volume":"35","author":"L Eder","year":"2008","unstructured":"Eder L, Zisman D, Barzilai M, Laor A, Rahat M, Rozenbaum M, Bitterman H, Feld J, Rimar D, Rosner I (2008) Subclinical atherosclerosis in psoriatic arthritis: a case-control study. J Rheumatol 35:877\u2013882","journal-title":"J Rheumatol"},{"key":"4528_CR34","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1136\/annrheumdis-2013-203433","volume":"73","author":"L Eder","year":"2013","unstructured":"Eder L, Chandran V, Gladman DD (2013) The Framingham Risk Score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease. Ann Rheum Dis 73:1990\u20131996","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4528_CR35","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.jbspin.2014.02.005","volume":"81","author":"R Ramonda","year":"2014","unstructured":"Ramonda R, Puato M, Punzi L, Rattazzi M, Zanon M, Balbi G, Ortolan A, Frallonardo P, Faggin E, Plebani M, Zaninotto M, Lorenzin M, Pauletto P, Doria A (2014) Atherosclerosis progression in psoriatic arthritis patients despite the treatment with tumor necrosis factor-alpha blockers: a two-year prospective observational study. Joint Bone Spine 81(5):421\u2013425","journal-title":"Joint Bone Spine"},{"key":"4528_CR36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/annrheumdis-2014-206617","volume":"74","author":"SL Kristensen","year":"2015","unstructured":"Kristensen SL, McInnes IB, Sattar N (2015) Psoriasis, psoriatic arthritis and cardiovascular risk: are we closer to a clinical recommendation? Ann Rheum Dis 74:321\u2013322","journal-title":"Ann Rheum Dis"},{"key":"4528_CR37","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/acr.22536","volume":"67","author":"FC Ernste","year":"2015","unstructured":"Ernste FC, S\u00e1nchez-Men\u00e9ndez M, Wilton KM, Crowson CS, Matteson EL, Maradit Kremers H (2015) Cardiovascular risk profile at the onset of psoriatic arthritis: a population-based cohort study. Arthritis Care Res 67:1015\u20131021","journal-title":"Arthritis Care Res"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04528-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04528-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04528-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T23:26:51Z","timestamp":1585610811000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04528-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,1]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["4528"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04528-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,1]]},"assertion":[{"value":"15 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study was carried out in compliance with the Helsinki Declaration. Internal Review Board approval was obtained from the Ethics Committee of Carmel Medical Center. Requirement for individual patient consent forms was waived due to the retrospective, observational nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}